Ryzodeg 100IU/ml Penfill 3 ml is used in the treatment of Diabetes (type 1 diabetes mellitus and type 2 diabetes mellitus). The detailed uses of Ryzodeg 100IU/ml Penfill 3 ml are as follows:

• Diabetes Management: Ryzodeg 100IU/ml Penfill 3 ml is primarily used to regulate blood glucose levels in individuals with diabetes mellitus, helping to keep them within a healthy range.
• Postprandial Blood Sugar Control: Ryzodeg 100IU/ml Penfill 3 ml effectively manages postprandial (after-meal) blood sugar spikes through its combination of intermediate and short-acting insulin.
• Type 1 and Type 2 Diabetes Treatment: Ryzodeg 100IU/ml Penfill 3 ml is prescribed for patients with Type 1 and Type 2 diabetes who are unable to achieve adequate glycemic control with oral hypoglycemic agents alone.

• Ryzodeg 100IU/ml Penfill 3 ml is an antidiabetic medicine primarily used for the treatment of both type 1 and type 2 diabetes mellitus.
• Ryzodeg 100IU/ml Penfill 3 ml works by ensuring rapid and consistent sugar control. It typically begins working after 60 minutes and is a long-acting insulin preparation (lasts for more than 24 hours). Together, they confirm rapid and stable sugar control by facilitating the reuptake of sugar in fat and muscle cells and suppressing the production of sugar in the liver.
• It prevents the risk of having severe complications of diabetes. It stimulates the recovery of sugar in muscle and fat cells, thereby suppressing sugar production in the liver.
• Ryzodeg 100IU/ml Penfill 3 ml helps improve glycaemic control, which in turn decreases the risk of complications of diabetes, such as damage to the retina (retinopathy), damage to the kidneys (nephropathy), impairment of nerve cells (neuropathy), delayed wound healing, diabetic foot ulcers, and others.
• Ryzodeg 100IU/ml Penfill 3 ml can also be safely prescribed to the diabetic mother during pregnancy and lactation.

• Follow your doctor's instructions regarding the dosage and duration of treatment.
• Ryzodeg 100IU/ml Penfill 3 ml should be administered subcutaneously (in the upper thigh, abdomen, upper arm, or buttocks).
• It should never be administered intravenously or into a vein.
• If you are not well-trained to self-administer it, ask a healthcare professional to administer it.

• Exercise may lower your body’s need for insulin during and for some time after the physical activity.
• Exercise may also speed up the insulin dose effect, especially if the exercise involves the injection site area (for example, the leg should not be used for injection just before running).
• Discuss with your doctor how you should adjust your insulin regimen to accommodate exercise.
• Avoid eating sugary food and prefer food cooked food low in calories.
• When travelling across more than 2 time zones, you should talk to your doctor about your insulin schedule adjustments.

• Inform your doctor if you are allergic to Ryzodeg 100IU/ml Penfill 3 ml.
• Do not take Ryzodeg 100IU/ml Penfill 3 ml if you have any low blood glucose levels, kidney, liver, or heart problems, or problems with alcohol or other prescription or recreational drugs.
• Please do not stop taking Ryzodeg 100IU/ml Penfill 3 ml of your own as it may cause withdrawal symptoms.
• Ryzodeg 100IU/ml Penfill 3 ml may decrease the level of potassium, leading to a state of hypokalaemia that, if left untreated, may lead to respiratory paralysis, irregular heartbeat rhythm, coma, and even death.
• Ryzodeg 100IU/ml Penfill 3 ml is for subcutaneous (under the skin) use only. If you are switching to a different insulin brand or using a different method of injection, it should be done under strict medical supervision.
• Cases of heart failure have been reported when pioglitazone was used with insulin, especially in patients at high risk of cardiac heart failure.
• The first symptoms of hyperglycemia (high blood sugar levels) may include excessive thirst, dry mouth, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, loss of appetite, and an acetone odour in the breath. You should closely monitor these symptoms.
• Do not consume alcohol, as it may either increase or decrease your blood glucose level.
• Care should be taken while travelling across more than two time zones. Your doctor may adjust your insulin schedule. 
• Ryzodeg 100IU/ml Penfill 3 ml is a cold chain medicine, and therefore it must be stored in the refrigerator at a temperature between 2-8 degrees Celsius, or else its efficiency may be compromised. Do not store in the freezer or the fridge.
• It is always important to check the expiry date of the medicine. Discard the medicine if it reaches the expiry date. Ryzodeg 100IU/ml Penfill 3 ml should not be administered intravenously (into the vein).